Transcranial magnetic stimulation combined with functional near-infrared spectroscopy to elucidate the neurophysiological mechanisms of post-stroke hemiplegia: a systematic review - Summary - MDSpire

Transcranial magnetic stimulation combined with functional near-infrared spectroscopy to elucidate the neurophysiological mechanisms of post-stroke hemiplegia: a systematic review

  • By

  • Yuzhe Zou

  • Xiangfeng Lai

  • Qian Liu

  • Hongmei Zhang

  • Hui Li

  • Wei Li

  • Dingwei He

  • Liqing Yao

  • Xue Yang

  • June 10, 2026

  • 0 min

Share

Objective:

To systematically synthesize clinical research evidence regarding the combined use of TMS and fNIRS in post-stroke motor function recovery, emphasizing its significance in enhancing rehabilitation outcomes and analyzing its neurophysiological mechanisms, clinical efficacy, and methodological quality.

Approach:
    Key Findings:
    • The TMS-fNIRS combined protocol was found to be safe and feasible.
    • Six out of nine interventional studies reported statistically significant improvements in motor function, such as Fugl-Meyer Assessment scores, particularly with interventions like intermittent theta-burst stimulation (iTBS) and high-frequency repetitive transcranial magnetic stimulation (rTMS).
    • Effective TMS interventions could enhance activation of the ipsilesional primary motor cortex and improve interhemispheric balance.
    • Two-thirds of the studies found significant correlations between neurophysiological changes and clinical function improvements.
    Interpretation:

    The combined TMS-fNIRS technology shows potential for advancing stroke rehabilitation toward individualization and closed-loop practice, suggesting a paradigm shift in therapeutic approaches.

    Limitations:
    • Small sample sizes in existing studies limit generalizability.
    • High protocol heterogeneity complicates comparisons.
    • Uneven methodological quality, particularly high risk of bias in non-randomized studies, affects the reliability of findings.
    Conclusion:

    Current evidence is still in the early stage, and future research should urgently focus on large-scale, standardized, algorithm-driven clinical trials to transition from 'proof-of-concept' to 'precision therapy'.

Original Source(s)

Related Content